UnitedHealth Group (UNH) Q3 2025 10-Q Quarterly Report
UnitedHealth Group (UNH) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 28, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
UnitedHealth Group Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • No quarterly revenue or YoY change disclosed in provided text
- • No profitability or margin figures included in provided section
- • No segment or product line performance details available
- • No cash position, operating cash flow, or capital deployment data mentioned
- • Management highlights multiple risks including regulatory changes, cyberattacks, legal actions, and public health crises impacting outlook
Risk Factors
- • No new risk factors added since 2024 10-K filing
- • Regulatory risk from healthcare policy changes remains significant and ongoing from prior disclosures
- • Operational risk tied to integration and management of diverse health services continues to impact clinical and financial performance
- • Competitive risk from evolving payer and provider landscape persists, affecting market share and growth opportunities
- • Financial risk related to liquidity and debt maturities unchanged, with no new currency or concentration exposures reported
UnitedHealth Group Q3 2025 Quarterly FinancialsXBRL
Revenue
$113.2B
▲ +12.2% YoY▲ +1.4% QoQ
Net Income
$2.3B
▼ -61.2% YoY▼ -31.1% QoQ
Net Margin
2.1%
▼ -393bp YoY▼ -98bp QoQ
Source: XBRL data from UnitedHealth Group Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other UnitedHealth Group Quarterly Reports
Get deeper insights on UnitedHealth Group
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.